These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39228526)

  • 1. Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China.
    Gao J; Liu C; Li Y; Chen X; Xue T; Tang Y
    Front Pharmacol; 2024; 15():1362374. PubMed ID: 39228526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of "4 + 7" volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis.
    Yang Y; Tong R; Yin S; Mao L; Xu L; Hao S; Mao Z
    BMC Health Serv Res; 2021 Nov; 21(1):1275. PubMed ID: 34823516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis.
    Wang X; He X; Zhang P; Zhang M; Ma R; Dai R; Li X
    Int J Equity Health; 2023 Sep; 22(1):200. PubMed ID: 37770924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of volume-based procurement policy on the usage and expenditure of first-generation targeted drugs for non-small cell lung cancer with EGFR mutation in China: an interrupted time series study.
    Wang X; Huang H; Sun Y; Zhu Z; Jiang B; Yang L
    BMJ Open; 2023 Jul; 13(7):e064199. PubMed ID: 37407064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis.
    Yang Y; Chen L; Ke X; Mao Z; Zheng B
    BMC Health Serv Res; 2021 Jul; 21(1):668. PubMed ID: 34238290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis.
    Hu S; Chen C; Yuan S; Xue F; Shi L; Fang Y; Yang C
    Front Pharmacol; 2019; 10():950. PubMed ID: 31555135
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis.
    Wang N; Yang Y; Xu L; Mao Z; Cui D
    BMC Public Health; 2021 Oct; 21(1):1883. PubMed ID: 34663282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of the "4+7" pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study.
    Wen X; Wang Z; Xu L; Luo J; Geng X; Chen X; Yang Y; Cui D; Mao Z
    Front Pharmacol; 2022; 13():829660. PubMed ID: 36060003
    [No Abstract]   [Full Text] [Related]  

  • 10. Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China.
    Tang Y; Liu C; Zhang X
    Appl Health Econ Health Policy; 2017 Feb; 15(1):57-64. PubMed ID: 27613726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series.
    Long H; Yang Y; Geng X; Mao Z; Mao Z
    Front Pharmacol; 2022; 13():944540. PubMed ID: 35910351
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
    Lan T; Guan L; Pang X; Li X; Yu Q
    J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pricing of HPV tests in Italian tender-based settings.
    Inturrisi F; Berkhof J
    J Med Econ; 2022; 25(1):762-768. PubMed ID: 35616231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus.
    Yuan J; Lu ZK; Xiong X; Lee TY; Huang H; Jiang B
    Front Pharmacol; 2022; 13():842944. PubMed ID: 35734415
    [No Abstract]   [Full Text] [Related]  

  • 15. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014.
    Hamzah NM; Perera PN; Rannan-Eliya RP
    BMC Health Serv Res; 2020 Jun; 20(1):509. PubMed ID: 32503539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients.
    Shang L; Cheng Y; Zhou J; Bao Y; Kong D; Huang R; Chen Y; Wang H; Gu N; Ma A
    Front Pharmacol; 2024; 15():1302154. PubMed ID: 38389928
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin.
    Zhao B; Wu J
    Int J Health Policy Manag; 2023; 12():7724. PubMed ID: 38618801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China.
    Yang Y; Hu R; Geng X; Mao L; Wen X; Wang Z; Hao S; Cui D; Mao Z
    Int J Health Plann Manage; 2022 May; 37(3):1650-1662. PubMed ID: 35132676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China.
    Tang Y; Liu C; Zhang Z; Zhang X
    Cost Eff Resour Alloc; 2018; 16():1. PubMed ID: 29371833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study.
    Guan X; Wushouer H; Yang M; Han S; Shi L; Ross-Degnan D; Wagner AK
    BMJ Open; 2019 Nov; 9(11):e031658. PubMed ID: 31784440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.